Skip to main content
Caplight Logo









AimingMed

AimingMed

Private
HangzhouHealthcare & Life Scienceshttps://aimingmed.com/

Last Round

Strategic

Jan 3, 2024

Total Funding Raised

$3.13M

Company Overview

AimingMed is a biotechnology company that specializes in organoid technology, providing precision treatment solutions, drug screening, and research services for oncology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

organoid technologydrug sensitivity testingprecision medicinetumor organoidsdrug discoveryorganoid biobanksingle-cell sequencinglab automationAI-driven drug screeningpatient-derived modelsorgan-on-a-chippersonalized oncologybiotech research services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AimingMed Comparables

Compare AimingMed with similar companies based on industry and business-model similarity.

AimingMed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Accurate International Biotechnology
93%
bioGenous Biotechnology
90%
K2 Oncology
88%

AimingMed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJan 3, 2024
Early FundingNov 7, 2022
AngelOct 1, 2021

AimingMed Investors

Notable investors and investment history

AimingMed investors
InvestorRounds
Yuanjing CapitalEarly Funding, Angel
Yantai Guofeng Investment Holding Group Co., Ltd.Strategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 3, 2024

    Led by Yantai Guofeng Investment Holding Group Co., Ltd.

  • Nov 7, 2022

    Raised capital from Yuanjing Capital.

AimingMed Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AimingMed Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AimingMed's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range8
Year Founded2020
Last FundingJan 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?